(1R)-1-(2,4-DICHLOROPHENYL)ETHAN-1-AMINE HCL, 96.0%, 1g

Diethyl Carbonate>98.0%(GC)500g

2-(4-(2-Butoxyethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 5g

2-(4-Methoxyphenoxy)acetic Acid>95.0%(GC)(T)25g

6-(3-Chloropropoxy)-2-(4-(3-chloropropoxy)phenyl)benzo[d]oxazole, 250mg

1-Benzyl-5-methyl-1H-[1,2,3]triazole-4-carboxylic acid, 97.0%, 250mg

cis-4-Oxo-4-(phenylamino)but-2-enoic acid, 97.0%, 5g

3-(2-chloroethyl)-6-methylpyrimidine-2,4(1H,3H)-dione, 95.0%, 1g

4-Bromo-7-fluoro-1H-indazole, 95.0%, 100g

Pointes de pipettes 5-300 μl, Standard, Boîte, Non stérile, 480 Pièces

N-Fmoc-N-(2-phenylethyl)-glycine, 97%, 250mg

Methyl 2-fluoro-4-nitrobenzoate, 95.0%, 10g

(R)-1-[3-(Trifluoromethyl)phenyl]ethylaminehydrochloride, 95.0%, 1g